NCT04500860

Low Dose Tadalafil for Treatment of Female OAB Syndrome: Short Term Follow up.

Low Dose Tadalafil 5mg for Treatment of Female Overactive Bladder Syndrome :6 Months Follow up

• Status: Completed
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 90 (actual)
• Sponsor: Kasr El Aini Hospital · Academic / Other
• Sex: Female
• Age: —
• Healthy volunteers: Not accepted

Summary

Evaluation of use of low dose tadalafil 5 mg daily for treatment of female OAB syndrome

Detailed description

90 female patients with overactive bladder syndrome divided into 3 groups group A subjected to daily low dose tadalafil 5 mg ,group B subjected to tolterodine and group C to placebo. They are evaluated as using OAB symptoms score for 6 months follow up

Conditions

• Female Patients With Overactive Bladder Syndrome or Female Patients With Urgency or Urgency Urinary Incontinence

Interventions

Type	Name	Description
DRUG	Low dose tadalafil 5 mg	Efficacy of daily low dose tadalafil 5mg for treatment of female overactive bladder syndrome or urgency with or without urgency urinary incontinence
DRUG	Tolterodine 4 Mg Oral Capsule, Extended Release	To compare efficacy of low dose tadalafil 5 mg to tolterodine 4 mg extended release in treatment of female overactive bladder
DRUG	Placebo	Placebo drugs

Timeline

• Start date: 2020-12-01
• Primary completion: 2022-07-01
• Completion: 2022-07-01
• First posted: 2020-08-05
• Last updated: 2022-08-15

Locations

1 site across 1 country: Egypt